Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and CAR-T cell therapy research.
Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma
SARS-CoV-2 infection of the oral cavity and saliva
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity
Non-conventional Inhibitory CD4+Foxp3–PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner